BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR

BRAIN Biotech AG 9M 2021/22: Key Takeaways Introduction to Brain’s Financials Q3-2022 Presentation This video features Michael Schneiders, Head of Investor Relations at Brain Biotech AG. Join us as Michael takes us through Brain’s Financials Q3-2022 Presentation. He will cover a range of topics, including Brain’s core values, their commitment to ESG and sustainability, Q3 highlights and lowlights, incubator exits, PHA121, the Brain incubator, financial highlights for 9M 2021/22, cash and cash flow, long-term revenue growth trajectory, risks related to supply chain and inflation, and FY21/22 guidance and mid-term targets. So sit back, relax, and let Michael guide you through Brain’s latest developments. Key Topics Covered in the Presentation Brain’s Core Values and ESG Commitment Q3-2022 Highlights and Lowlights Incubator Exits and PHA121 Financial Highlights for 9M 2021/22 Risks Related to Supply Chain and Inflation FY21/22 Guidance and Mid-Term Targets Other videos: ⁠Elevator Pitch⁠ ⁠Company Presentation⁠ ⁠Deep Dive Presentation⁠ ⁠Financial Results Presentation⁠ ⁠ESG Presentation⁠ T&C: This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on ⁠www.seat11a.com/legal⁠ and ⁠www.seat11a.com/imprint⁠.